{"id":"doi:10.1038/s41591-020-0840-5","kind":"article","title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","authors":["You Lü","Jianxin Xue","Tao Deng","Xiaojuan Zhou","Kun Yu","Lei Deng","Meijuan Huang","Xin Yi","Maozhi Liang","Yu Wang","Haige Shen","Ruizhan Tong","Wenbo Wang","Li Li","Jin Sook Song","Jing Li","Xiaoxing Su","Zhenyu Ding","Youling Gong","Jiang Zhu","Yongsheng Wang","Bingwen Zou","Yan Zhang","Yanying Li","Lin Zhou"],"author_count":38,"year":2020,"published":"2020-04-27","venue":"Nature Medicine","cited_by":541,"doi":"10.1038/s41591-020-0840-5","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-020-0840-5","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-020-0840-5","updated":null,"pmid":"32341578","pmcid":null,"openalex_id":"W3019413961","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["CAR-T cell therapy research"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}